Table 3.
QOF points and disease prevalence in each clinical domain by practice size.
| Number of WTE GP principals | |||||
|---|---|---|---|---|---|
| Single-handed (1.00 WTE GP) | Small practice (1.01–3.00 WTE GPs) | Medium practice (3.01–5.00 WTE GPs) | Large practice (5.01 GPs) | P-valuea,b | |
| Asthma points, median (range) | 71.7 (29.9–72.0) | 70.2 (19.8–72.0) | 70.0 (28.8–72.0) | 69.9 (24.5–72.0) | 0.164 |
| Asthma prevalence (%) | 5.04 | 5.21 | 5.28 | 5.52 | 0.017 |
| Cancer points, median (range) | 12.0 (0–12.0) | 12.0 (0–12.0) | 12.0 (6.0–12.0) | 12.0 (6.0–12.0) | c |
| Cancer prevalence (%) | 0.50 | 0.46 | 0.50 | 0.51 | 0.087 |
| COPD points, median (range) | 44.7 (15.1–45.0) | 43.2 (13.1–45.0) | 44.5 (14.7–45.0) | 43.9 (11.0–45.0) | 0.020 |
| COPD prevalence (%) | 2.12 | 2.29 | 1.84 | 1.82 | <0.001 |
| Diabetes points, median (range) | 98.1 (76.4–99.0) | 97.6 (63.3–99.0) | 97.5 (69.4–99.0) | 97.0 (64.7–99.0) | 0.288 |
| Diabetes prevalence (%) | 3.22 | 3.15 | 3.13 | 3.14 | 0.935 |
| Epilepsy points, median (range) | 15.0 (2.0–16.0) | 14.1 (2.0–16.0) | 14.4 (2.2–16.0) | 14.9 (2.0–16.0) | 0.112 |
| Epilepsy prevalence (%) | 0.65 | 0.75 | 0.69 | 0.72 | 0.029 |
| Hypertension points, median (range) | 105.0 (72.1–105.0) | 105.0 (40.4–105.0) | 105.0 (67.6–105.0) | 104.9 (60.1–105.0) | c |
| Hypertension prevalence (%) | 10.54 | 11.27 | 11.33 | 11.07 | 0.487 |
| Hypothyroidism points, median (range) | 8.0 (7.0–8.0) | 8.0 (6.1–8.0) | 8.0 (6.9–8.0) | 8.0 (2.4–8.0) | c |
| Hypothyroidism prevalence (%) | 2.13 | 2.51 | 2.71 | 2.79 | <0.001 |
| Mental health points, median (range) | 38.8 (7.0–41.0) | 40.8 (0–41.0) | 41.0 (7.2–41.0) | 41.0 (14.4–41.0) | c |
| Mental health prevalence (%) | 0.77 | 0.60 | 0.53 | 0.53 | 0.008 |
| Stroke points, median (range) | 30.4 (15.6–31.0) | 30.6 (12.3–31.0) | 30.7 (14.1–31.0) | 30.8 (15.2–31.0) | 0.486 |
| Stroke prevalence (%) | 1.57 | 1.72 | 1.78 | 1.79 | 0.225 |
| CHD points, median (range) | 119.5 (84.2–121.0) | 117.9 (72.4–121.0) | 119.9 (80.9–121.0) | 120.5 (63.8–121.0) | <0.0001 |
| CHD prevalence (%) | 3.76 | 3.74 | 3.70 | 3.75 | 0.960 |
a
Median was compared across practice size using the median test.
b
Results for test of mean prevalence were population weighted.
c
Where medians are close to being identical, or are identical, the median test incorporated in STATA 9.2 will not report a test statistic or P value.
CHD = coronary heart disease. COPD = chronic obstructive pulmonary disease. WTE = whole time equivalents.